// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Non-verbal Communication of Nursing Home Residents and Care Staff

Zunera Khan - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Divergent patterns of cognitive deficits and structural brain alterations between older adults in mixed-sex and same-sex relationships

Anthony N Correro - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Feasibility analysis of the design of a psychosocial intervention in dementia: Sensitivity analysis

Rubén Rabaneda-Bueno - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

PROTECT Norge: Online assessment of potentially modifiable risk factors for dementia on cognitive performance in a Norwegian ageing cohort.

Ingelin Testad - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

The burden of COVID-19 on all-cause mortality in older adults living in Wales

Helen Lai - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

- The Deep Dementia Phenotyping (DEMON) Network: A global platform for innovation using data science and artificial intelligence

Janice M Ranson - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

Methadone hydrochloride

- A digital biomarker for remote self-assessment of Alzheimer’s Diseases: development and validation.

Joe Butler - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Social health factors and dementia risk – assessing potential pathways in a population-based cohort study

Lukas Duffner - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

A Comprehensive Literature Search of Digital Health Technology Use in Dementia: Digital Tools to Support Dementia Caregivers

John Spreadbury - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Narrative Design for Dementia Care: arranging the built environment of care homes to aid communication.

Loukia Minetou - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Dementia

N/A

Measurement of social connection in people with dementia living in care homes

Andrew Sommerlad - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Social connection in long-term care home residents: a review of research on health outcomes and strategies during COVID-19

Jennifer Bethell - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Normative data for three physical frailty parameters in an aging, rural Indian population

KARRU VENKATA RAVI TEJA - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

- Monitoring abnormal nocturnal behaviour in the homes of patients living with dementia ¶

Eyal Soreq - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

- Machine learning-based prediction of cognitive outcomes in de novo Parkinson's disease

Joshua Harvey - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

- Translational potential of JAX humanized APOE mice: trajectories of resilient versus susceptible aging by sex and weight

Simona Merlini - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

- Plasma neurofilament light chain in cognitively unimpaired late middle-aged & older adult APOE ε4 homozygotes, heterozygotes, & non-carriers from the Arizona APOE Cohort

Valentina Ghisays - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Psychometric Characteristics of the Amsterdam Instrumental Activities of Daily Living Questionnaire in healthy individuals and NIA-AA stages of preclinical Alzheimer’s Disease

Sietske A.M. Sikkes - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

- Validation of a continuous model of amyloid-β CSF/PET discordance across cohorts and PET tracers

Elena Rodriguez-Vieitez - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

18F-flutemetamol

Increased cerebral blood flow is associated with higher baseline amyloid burden in a cognitively unimpaired population

Beatriz E. Padrela - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved